{
  "docId": "019de071-38a0-778d-8d39-45a206af86ac",
  "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e",
  "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 44,
  "pageCount": 69,
  "prevPage": 43,
  "nextPage": 45,
  "slideType": "before_after",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses a horizontal progression arrow to show the transition from initial indication to adjacent indications.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/44",
  "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac",
  "deckJsonHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac.json",
  "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-44",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.94,
        "x": 0.03,
        "y": 0.238
      },
      "kind": "diagram",
      "text": "SKIN BLISTERING DISEASES – AUTOANTIBODY DRIVEN",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d4bf107-121e-4242-ab3f-397fc320b06c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.52,
        "y": 0.38
      },
      "kind": "list",
      "text": "...Before Expansion into Adjacent Indications. Autoantibodies initiate disease, Pathophysiology of blister formation more heterogeneous, Larger yet more elderly, fragile population, Important to confirm efgartigimod profile in pemphigus",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92392e25-49b0-4e85-8b8d-00db94d32a70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.03,
        "y": 0.38
      },
      "kind": "list",
      "text": "Proof of Concept in Initial Indication... Fast onset of action, 90% disease control after median time of 17 days, Significant responses, 64% complete clinical remission after median 92 days, Corticosteroid sparing potential, Favorable tolerability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1c5df6a-30f3-4791-b161-0848400e5a06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Pemphigus Serves as Proof of Concept for Autoimmune Blistering Diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82ffb2e1-c77f-45ba-a689-c8d3ab6b6057",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before/after framing",
      "slug": "before-after-framing",
      "agent": null,
      "layer": "slide",
      "matchId": "26a1c4a6-9271-4348-a36a-2b8b0ddd5bbc",
      "evidence": "The slide compares outcomes before and after treatment",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "6d3a6819-a523-403b-90c6-7bf710696f36",
      "evidence": "The slide contrasts the current proof-of-concept status in Pemphigus with the future expansion into Bullous Pemphigoid.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}